With study protocols are becoming more complex with changes that require amendments it is crucial to find a partner that can define, build, test, confirm, and deploy quality studies.
IRT USA 2018 resonating themes - the need for better project management and never losing sight that the patient is at the center of everything we do.
With the continued modernization and complexity of clinical trials in which a one-size-fits-all approach simply does not work it is important to understand the growing trend of drug pooling.
When a drug is required for both commercial and extended clinical trial use, this may cause strain on supply and demand operations. Discover how Almac Clinical Services used a pooled inventory strategy and Just In Time labelling (JTL) approach to maximize drug supply and minimize wastage.
How IRT vendor relationships can ensure high quality builds that meet pharma companies' needs and avoid the potential pitfalls associated with RTSM.
How to address the unique challenges of finding the right balance between drug overage and outage, ensuring every patient receives the right medication when they need it, and managing clinical trial supply.
Clinical oncology trials are more complex and time consuming than those in any other therapeutic area and failure rates are frustratingly high. Given the urgent need for new oncologic therapies, sponsors are eager to find more effective ways to conduct clinical research.
Research in diagnosis, management, and therapy development, as well as development of standardized guidelines for upcoming studies need to be addressed in order to improve the prognosis of DFI patients.
Why condensing a study’s findings concise presentation, in an easily understood and digestible format is harder than it appears.
In order to increase the number of potentially successful clinical development projects in the microbiome space, it will be important to recognize standard drug development principles and global drug or biologic development requirements.
|
|
|
|
|
|
|
|
|